Back to Search
Start Over
64 - Preclinical comparison of the blood brain barrier (BBB) permeability of osimertinib (AZD9291) with other irreversible next generation EGFR TKIs.
- Source :
-
European Journal of Cancer . Dec2016 Supplement 1, Vol. 69, pS28-S28. 1p. - Publication Year :
- 2016
Details
- Language :
- English
- ISSN :
- 09598049
- Volume :
- 69
- Database :
- Academic Search Index
- Journal :
- European Journal of Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 120141027
- Full Text :
- https://doi.org/10.1016/S0959-8049(16)32664-8